(Q45795500)

16 December 2017

title

Detection of anti-HBc IgM following prednisone treatment in patients with chronic active hepatitis B virus infection (English)

1 reference

16 December 2017

1 reference

Nowicki MJ

1

1 reference

16 December 2017

Tong MJ

series ordinal

2

1 reference

16 December 2017

Nair PV

series ordinal

3

1 reference

16 December 2017

Stevenson D

series ordinal

4

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 November 1984

1 reference

16 December 2017

published in

Hepatology

1 reference

16 December 2017

volume

4

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

page(s)

1129-1133

1 reference

16 December 2017

Detection and Persistence of Specific IgM Antibody to Coxiella burnetii by Enzyme-Linked Immunosorbent Assay: A Comparison with Immunofluorescence and Complement Fixation Tests

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

Reactivation of chronic hepatitis B virus infection by cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

Detection of IgM Antibodies to Cytomegalovirus (CMV) Using an Enzyme-labelled Antigen (ELA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Serodiagnosis of recent hepatitis B infection by IgM class anti-HBc

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

The significance of IgM antibodies to hepatitis B core antigen in hepatitis B carriers and hepatitis B-associated chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Presence and meaning of anti-HBc IgM as determined by ELISA in patients with acute type B hepatitis and healthy HBsAg carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Prevalence and Significance of Anti-HBc IgM (Radioimmunoassay) in Acute and Chronic Hepatitis B and in Blood Donors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

DNA of a human hepatitis B virus candidate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Corticosteroids and Lymphoid Cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Effect of Corticosteroids on Suppressor-Cell Activity in Autoimmune and Viral Chronic Active Hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Differential effects of glucocorticosteroids on the functions of helper and suppressor T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Cell-mediated immunity in acute and chronic hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Effect of hydrocortisone on the in vitro human antibody response: interaction with monocytes and prostaglandins.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Immunoglobulin production induced in vitro by glucocorticoid hormones: T cell-dependent stimulation of immunoglobulin production without B cell proliferation in cultures of human peripheral blood lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

T cell-replacing factor for glucocorticosteroid-induced immunoglobulin production. A unique steroid-dependent cytokine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Mechanisms of liver cell injury in acute and chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity (ADCC) in patients with acute and chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040606

7 January 2021

Identifiers

DOI

10.1002/HEP.1840040606

1 reference

16 December 2017

1 reference

16 December 2017